We are live on
!
Find out more
CAM
Claret Asset Management Portfolio holdings
AUM
$928M
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.71%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
–
AUM
$610M
AUM Growth
+$71.1M
(+13%)
Cap. Flow
+$18.3M
Cap. Flow
% of AUM
3.01%
Top 10 Holdings %
Top 10 Hldgs %
38.82%
Holding
213
New
18
Increased
40
Reduced
90
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QIPT
Quipt Home Medical
QIPT
|
+$16.9M |
| 2 |
Dollar Tree
DLTR
|
+$2.9M |
| 3 |
Ubiquiti
UI
|
+$1.97M |
| 4 |
Ollie's Bargain Outlet
OLLI
|
+$1.57M |
| 5 |
AbbVie
ABBV
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRHM
CRH Medical Corporation
CRHM
|
+$781K |
| 2 |
XPEL
XPEL
|
+$750K |
| 3 |
Varex Imaging
VREX
|
+$741K |
| 4 |
TFI International
TFII
|
+$554K |
| 5 |
IBDN
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
|
+$505K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23% |
| 2 | Financials | 15.63% |
| 3 | Healthcare | 14.48% |
| 4 | Communication Services | 12% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDHL
126
Redhill Biopharma
RDHL
$3.95M
| $378K | 0.06% |
55
| – | – |
|
|
FYBR
127
DELISTED
Frontier Communications
FYBR
| $374K | 0.06% |
+14,154
| New | +$357K |
|
128
Cable One
CABO
$254M
| $371K | 0.06% |
194
| – | – |
|
|
IBDQ
129
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $364K | 0.06% |
13,500
-3,735
| -22% | -$101K |
|
130
iShares MSCI Brazil ETF
EWZ
$9.22B
| $360K | 0.06% |
8,869
| – | – |
|
131
Capri Holdings
CPRI
$1.88B
| $352K | 0.06% |
6,156
| – | – |
|
132
Bank of America
BAC
$437B
| $350K | 0.06% |
8,499
-610
| -7% | -$25K |
|
133
iShares Core US Aggregate Bond ETF
AGG
$137B
| $346K | 0.06% |
3,000
-2,000
| -40% | -$229K |
|
134
OR Royalties Inc
OR
$5.71B
| $327K | 0.05% |
23,895
-3,680
| -13% | -$49.2K |
|
135
ARK Genomic Revolution ETF
ARKG
$1.6B
| $315K | 0.05% |
3,410
| – | – |
|
136
Suncor Energy
SU
$77.9B
| $313K | 0.05% |
13,091
-4,327
| -25% | -$99.3K |
|
137
Waters Corp
WAT
$36.8B
| $313K | 0.05% |
907
| – | – |
|
138
Vanguard Total World Stock ETF
VT
$78B
| $312K | 0.05% |
3,010
-210
| -7% | -$21.4K |
|
|
NVO
139
Novo Nordisk
NVO
$208B
| $307K | 0.05% |
7,322
| – | – |
|
140
H&R Block
HRB
$5.73B
| $306K | 0.05% |
13,042
-140
| -1% | -$3.31K |
|
141
Franco-Nevada
FNV
$41.4B
| $303K | 0.05% |
2,090
-500
| -19% | -$72.3K |
|
142
Invesco DB Agriculture Fund
DBA
$1.24B
| $296K | 0.05% |
15,885
-440
| -3% | -$8.03K |
|
143
Generac Holdings
GNRC
$11.9B
| $291K | 0.05% |
700
| – | – |
|
144
Mastercard
MA
$500B
| $287K | 0.05% |
787
-25
| -3% | -$9.29K |
|
145
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.46B
| $286K | 0.05% |
6,110
| – | – |
|
146
Fortis
FTS
$28.9B
| $286K | 0.05% |
6,474
-194
| -3% | -$8.74K |
|
147
Aptiv
APTV
$12.1B
| $278K | 0.05% |
1,769
| – | – |
|
148
Caterpillar
CAT
$382B
| $277K | 0.05% |
1,272
| – | – |
|
149
McDonald's
MCD
$188B
| $274K | 0.04% |
1,188
+31
| +3% | +$7.21K |
|
150
HP
HPQ
$24.8B
| $270K | 0.04% |
8,930
-155
| -2% | -$4.95K |
|
Similar funds
WC
BCC
GP
ICM
TC
CFA
FPI
MHIC
Claret Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Claret Asset Management held 213 positions worth $610M, up 13% from $539M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Claret Asset Management deployed $18.3M of net new capital in Q2 2021, opening 18 new positions and adding to 40 existing holdings. Its largest new stake was Quipt Home Medical: 2,765,085 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was XPEL, an estimated $750K trimmed.
- Claret Asset Management's largest Q2 2021 buy was Quipt Home Medical: 2,765,085 shares worth $17.2M.
- Claret Asset Management added most to Dollar Tree in Q2 2021, an estimated $2.9M increase.
- Claret Asset Management's biggest Q2 2021 reduction was XPEL, cutting an estimated $750K.
- Claret Asset Management fully exited CRH Medical Corporation in Q2 2021, selling an estimated $781K.
- Claret Asset Management's ten largest holdings make up 39% of its $610M portfolio in Q2 2021.
- Claret Asset Management opened 18 new positions and closed 10 in Q2 2021.
- Claret Asset Management's portfolio value rose 13% quarter-over-quarter to $610M.
Based on Claret Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.